Stockpiling oseltamivir: Roche clarifies data for improved mortality with oseltamivirBMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1203-b (Published 17 November 2005) Cite this as: BMJ 2005;331:1203
- James R Smith (firstname.lastname@example.org), international medical leader,
- Regina Dutkowski, clinical science leader
- F Hoffman-La Roche, CH-4070 Basel, Switzerland
- Hoffmann-La Roche, Nutley, NJ 07110, USA
EDITOR—Experts question the wisdom of stockpiling oseltamivir (Tamiflu).1 A question was asked about data supporting an improvement in mortality with the drug.
Two datasets were presented at the second European Influenza Conference in Malta (http://www.eswi.org/) in September. A large retrospective cohort study of patients with influenza-like illness (n= 176 001) taken from a US health database showed …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial